Clinical Trial

Natural Course and Molecular Basis of Alpha 1- Antitrypsin Deficiency-associated Liver Disease.

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
* To define the course of AATD-associated liver disease. * To use the obtained samples for biomedical research which includes: 1. Search for serum-based disease biomarkers and the associated molecular pathways. 2. Multi-omic spatial analysis of human AATD-LD.
Trial Details
NCT Number NCT07639996
Lead Sponsor Assiut University
Conditions Alpha 1-antitrypsin Deficiency (AATD)
Enrollment 45 participants
Start Date 2026-10-01
Primary Completion 2027-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-10